Objective: To evaluate the efficacy of oral meloxicam, topical anaesthetic cream and cautery iron in mitigating acute nociceptive responses of pigs to tail docking.

Study Design: A prospective, randomized, controlled experimental study.

Animals: A total of 40 healthy Large WhitexLandrace pigs aged 21±1 days, weighing 6.1±0.9 kg.

Methods: Pigs were randomly assigned to one of four treatments (n=10 per treatment): CONTROL: docked using clippers without analgesia; MEL: docked using clippers after administration of oral meloxicam; EMLA: docked using clippers after application of topical anaesthetic cream; and CAUT: docked using a cautery iron without analgesia. Anaesthesia was induced and maintained with halothane in oxygen. Following induction, end-tidal halothane was stabilized at 0.95-1.05% and electroencephalograph (EEG) recording commenced. After 5 minutes of baseline data collection, tail docking was performed and recording continued for a further 10 minutes. The EEG summary variables median frequency (F50), 95% spectral edge frequency (F95) and total power (P) were calculated for the baseline period and for consecutive 30-second intervals following docking.

Results: Following docking, F50 increased and P decreased significantly in CONTROL and MEL pigs. EMLA pigs exhibited no change in any variable, whilst CAUT pigs exhibited a reduction in P but no change in F50. F50 was higher in control pigs than in EMLA pigs 30-60 seconds after docking (p≤0.01). P was lower in CONTROL than in EMLA pigs 30-90 seconds after docking (p<0.03) and in CAUT pigs 60 seconds after docking (p=0.01).

Conclusions And Clinical Relevance: Prior application of EMLA cream abolished EEG indicators of nociception in pigs docked using clippers. Docking using a cautery iron without analgesia ameliorated EEG indicators of nociception, relative to using clippers without analgesia. Prior administration of EMLA cream or the use of cautery instead of clippers may reduce the acute pain experienced by pigs undergoing tail docking.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaa.2017.02.004DOI Listing

Publication Analysis

Top Keywords

oral meloxicam
12
topical anaesthetic
12
anaesthetic cream
12
cautery iron
12
docked clippers
12
emla pigs
12
pigs
10
meloxicam topical
8
cream cautery
8
iron mitigating
8

Similar Publications

Effects of lidocaine-plus-meloxicam treatment on behavioral and physiological changes, and leukocyte heat shock protein 90 gene expression after surgical castration in Hanwoo bulls.

Front Vet Sci

December 2024

Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea.

This study examined the effects of surgical castration and lidocaine-plus-meloxicam treatment on growth, physiology, behaviors, and leukocyte heat shock protein 90 (HSP 90) gene expression in Hanwoo (Korean cattle) bulls. Twenty Hanwoo bulls (body weight 248.8 ± 28.

View Article and Find Full Text PDF

Diagnosis of in a fledgling kererū ().

N Z Vet J

December 2024

Diagnostic and Surveillance Services, Biosecurity New Zealand, Ministry for Primary Industries, Wellington, New Zealand.

In early summer, a wild fledgling kererū () was admitted to a wildlife hospital in Dunedin after falling from its nest and being found on the ground. The bird was underweight, weighing only 391 g (expected weight > 450 g), and determined to be in poor body condition based on palpation of pectoral muscle mass. There was bilateral periorbital swelling and ocular discharge with caseous material blocking the choana.

View Article and Find Full Text PDF

Pharmacokinetics of Meloxicam in Different Animal Species: A Comprehensive Review.

Vet Sci

October 2024

Pharmacology, Department of Biomedical Sciences, Veterinary Faculty, Institute of Biomedicine (IBIOMED), University of Leon, 24071 Leon, Spain.

Meloxicam is a non-steroidal anti-inflammatory in the oxicam group. It has been extensively used in human and veterinary medicine for their anti-inflammatory, analgesic and antipyretic activities. Meloxicam has shown high therapeutic potential for disorders such as osteoarthritis, musculoskeletal disorder, acute respiratory infection, puerperal septicemia, mastitis and mastitis-metritis-agalactia syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed 51 rabbits diagnosed with dental disease over a decade to evaluate the outcomes of various treatments and their complications.
  • It found that rabbits treated with coronal reduction had no significant complications, while 41% faced issues after dental extractions, like incomplete extractions and 25% struggled with complications from periapical infections.
  • The importance of discussing the risk of complications is emphasized, especially since dental disease is a common reason for veterinary care in rabbits, with some cases leading to natural death or euthanasia.
View Article and Find Full Text PDF

Mesoporous Polydopamine Nanotherapeutics for MRI-Guided Cancer Photothermal and Anti-Inflammatory Therapy.

Int J Nanomedicine

October 2024

School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.

Article Synopsis
  • Photothermal therapy (PTT) shows promise in combating cancer but faces challenges, including inflammation and recurrence risks; combining PTT with anti-inflammatory treatments may improve its effectiveness.
  • The study developed mesoporous dopamine nanoparticles (MAGM NPs) using Gd, arginine, and the anti-inflammatory drug meloxicam, aiming to enhance anti-cancer and anti-inflammatory effects while enabling MRI imaging.
  • Test results on a mouse model of breast cancer revealed that MAGM NPs improved targeted anticancer effects under MRI guidance, while also boosting photothermal efficiency and reducing inflammation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!